Vertex Pharmaceuticals
VRTX
#171
Rank
โ‚ฌ115.35 B
Marketcap
455,40ย โ‚ฌ
Share price
1.36%
Change (1 day)
25.07%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ6.40 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ6.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ5.93 B0.93%
2024-12-31โ‚ฌ5.88 B26.32%
2023-12-31โ‚ฌ4.65 B17.91%
2022-12-31โ‚ฌ3.95 B34.27%
2021-12-31โ‚ฌ2.94 B18.09%
2020-12-31โ‚ฌ2.49 B25%
2019-12-31โ‚ฌ1.99 B25.95%
2018-12-31โ‚ฌ1.58 B26.29%
2017-12-31โ‚ฌ1.25 B-15.42%
2016-12-31โ‚ฌ1.48 B15.32%
2015-12-31โ‚ฌ1.28 B26.18%
2014-12-31โ‚ฌ1.01 B46.09%
2013-12-31โ‚ฌ0.69 B-41.02%
2012-12-31โ‚ฌ1.18 B20.31%
2011-12-31โ‚ฌ0.98 B6.98%
2010-12-31โ‚ฌ0.91 B53.14%
2009-12-31โ‚ฌ0.59 B13.04%
2008-12-31โ‚ฌ0.53 B134.58%
2007-12-31โ‚ฌ0.22 B-28.21%
2006-12-31โ‚ฌ0.31 B20.44%
2005-12-31โ‚ฌ0.26 B-30.44%
2004-12-31โ‚ฌ0.37 B-10.95%
2003-12-31โ‚ฌ0.42 B0.97%
2002-12-31โ‚ฌ0.41 B-17.89%
2001-12-31โ‚ฌ0.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ103.64 B 1,517.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ125.88 B 1,865.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ33.58 B 424.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ78.40 B 1,123.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ58.31 B 810.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚ฌ0.17 B-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA